By Mill Chart
Last update: Nov 22, 2023
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) was identified as a stock worth exploring by dividend investors by our stock screener. NYSE:BMY scores well on profitability, solvency and liquidity. At the same time it seems to pay a decent dividend. We'll explore this a bit deeper below.
ChartMill assigns a Dividend Rating to every stock. This score ranges from 0 to 10 and evaluates the different dividend aspects, including the yield, the growth and sustainability. NYSE:BMY scores a 7 out of 10:
ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:BMY scores a 5 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:BMY has earned a 8 out of 10:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Check the latest full fundamental report of BMY for a complete fundamental analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
BRISTOL-MYERS SQUIBB CO
NYSE:BMY (4/19/2024, 7:04:00 PM)
After market: 48.93 0 (0%)48.93
+0.63 (+1.3%)
These stocks pay between 3.2% and 6.7% in dividends.
These stocks pay between 3.2% and 6.7% in dividends.
Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.
These income stocks look like good options at current levels.
The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The future of the U.S. economy appears promising, with robust growth and strong...
The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?